Caprolactam Market Faces Downward Pressure Amid Weak Demand and Cost Support

The caprolactam market is experiencing a persistent downward trend, driven by weakened cost support and a seasonal drop in demand. In India, as well as in other major markets like China and Germany, prices have been under pressure due to a combination of factors including falling upstream raw material costs and subdued purchasing interest from downstream industries.

In India, the domestic caprolactam market is grappling with a "triple whammy" of weak cost support, ample supply, and sluggish demand. Prices for upstream raw materials such as pure benzene and sulfur have declined, eroding production cost support. Operating rates remain moderate, ensuring sufficient supply, but downstream sectors like textiles and automotive manufacturing are in their traditional off-season, further squeezing profit margins.

As of June 11, benchmark price for caprolactam in India stood at 11,120 RMB/ton, reflecting a cumulative drop of over 13% from the May peak. East China, a core hub for production and distribution, reports mainstream delivered prices at 11,000–11,200 RMB/ton, while Shandong sees even lower ex-factory prices, marking the lowest nationwide.

Globally, the situation mirrors India's challenges. In July 2025, caprolactam prices in China and Germany also fell due to similar issues of weak demand and lack of cost-push drivers. Despite steady production, market sentiment remains bearish, with downstream industries adopting cautious procurement strategies. Supply chain disruptions have had minimal impact due to the already low demand.